Safety And Tolerability Study Of RN6G In Patients With Dry, Age-Related Macular Degeneration
Public ClinicalTrials.gov record NCT00877032. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase I, Double-masked, Placebo-controlled Study Evaluating The Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, And Immunogenicity Of Single Escalating Doses Of Rn6g In Patients With Dry, Age-related Macular Degeneration (Amd)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine the safety and tolerability of RN6G in patients with dry, age-related macular degeneration.
Study identification
- NCT ID
- NCT00877032
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 57 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2009 (Type not available)
- Primary completion
- Jul 2011 (Actual)
- Completion
- Jul 2011 (Actual)
- Last update posted
- Mar 31, 2015
2009 – 2011
United States locations
- U.S. sites
- 20
- U.S. states
- 5
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Dedicated Phase 1 | Phoenix | Arizona | 85013 | — |
| Retinal Consultants of AZ | Phoenix | Arizona | 85014 | — |
| Insight Diagnostic Imaging Center | Phoenix | Arizona | 85015 | — |
| Amir Hedayati-Rad, MD | Glendale | California | 91206 | — |
| United Medical Imaging | Inglewood | California | 90301 | — |
| United Medical Research Institute | Inglewood | California | 90301 | — |
| California Pharmacy and Compounding Center | Newport Beach | California | 92660 | — |
| Jasper Clinic, Inc. | Kalamazoo | Michigan | 49007 | — |
| Jonathan Rowe, MD | Kalamazoo | Michigan | 49048 | — |
| Ronald VanderLugt, MD | Kalamazoo | Michigan | 49048 | — |
| CEDRA Clinical Research, LLC | San Antonio | Texas | 78217 | — |
| Village Drive Imaging Center | San Antonio | Texas | 78217 | — |
| Specialty MRI | San Antonio | Texas | 78229 | — |
| Medical Center Ophthalmology Associates | San Antonio | Texas | 78233 | — |
| Medical Center Ophthalmology Associates | San Antonio | Texas | 78240 | — |
| Retinal Consultants of San Antonio | San Antonio | Texas | 78240 | — |
| EZ Pass Rx | Bountiful | Utah | 84010 | — |
| Lifetree Clinical Research | Salt Lake City | Utah | 84106 | — |
| Rocky Mountain Eye Care Associates, LC | Salt Lake City | Utah | 84107 | — |
| Western Neurological Associates | Salt Lake City | Utah | 84124 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00877032, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 31, 2015 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00877032 live on ClinicalTrials.gov.